List of Participants to the workshop on Intellectual Property, Health Care and International Trade Agreements May 7 and 8, 1998 Washington DC

USA

Syed Rizwanuddin Ahmad: Medical Information Specialist, United States Pharmacopeia (USP)
Peter S. Arno: Department of Epidemiology and Social Medicine, Montefiore Medical Center, Yeshiva University, Bronx, NY
Jonathan Band: Morrison & Foerster LLP, Washington DC
Chuck Bell: Consumers Union, New York
Nancy Blum: Coordinator of International Programs, Division of Information Development, United States Pharmacopeia (USP)
Lora Burgess: Maryland United for Peace and Justice
Jillian Cohen: Pharmaceutical Consultant, World Bank
Matthew Daynard: Senior Attorney, Bureau of Consumer Protection, United States Federal Trade Commission
Kristin Dawkins: Institute for Agriculture and Trade Policy, Minneapolis
Jennifer Devine: Attorney, United States Pharmacopeia (USP)
Joseph DiMasi: Center for Study of Drug Development, Tufts University, Boston
Abby Dodd: Latin America Specialist, Verner Liipfert Consulting Services Inc, Washington DC
Sharon Donovan: Alexis de Tocqueville Institution, Arlington VA
Diane E. Dorman: Manager, Communications, The Generic Pharmaceutical Industry Association (GPIA), Washington DC
David L. Durkin: Olsson, Frank and Weeda, P.C., Washington DC
Hamideh Erehi
Susan K. Finston: Office of Intellectual Property, United States Department of State
James F. Flug: Duncan, Weinberg, Miller & Pembroke, P.C., Washington DC
Sibylle Frucht: Delegation of the European Commission, Washington DC
Naoko Fujii: Attorney, New York
Catherine Gavin: Consumer Project on Technology, Washington DC
Celine Gounder: Project Manager, Princeton Project 55 Tuberculosis Initiative, Washington DC
Dan Greifenberger: United for Peace and Justice, Baltimore, MD
William F. Haddad: Chairman and CEO, MIR Pharmaceutical Inc, Brenster NY
Annette Hamburger: Senior Attorney, Office of the Legal Advisor, National Institute of Health, Bethesda, MD
Richard Hinson: Office of Intellectual Property, United States Department of State
Richard A. Lambert: Counsel for Intellectual Property, Office of the General Counsel, National Institute of Health, Bethesda, MD
Fabiana Jorge: Verner Liipfert Consulting Services Inc, Washington DC
David Langdon
Thelma Leaffer: Delta Square Associates, Bethesda, MD
Jamie Love: Director, Consumer Project on Technology, Washington DC
Kristina M. Lybecker: Department of Economics, University of California, Berkley, CA
James McGlinchey: Chief, Office of Intellectual Property and Competition Policy, United States Departement of State
Wendy L. McGoodwin: Council for Responsible Genetics, Cambridge, MA
Charles McMillion: President & Chief Economist, MBG Information Services, Washington DC
H.W. "Buddy" Menn III: Vice President for Legislative Affairs, The Generic Pharmaceutical Industry Association (GPIA), Washington DC
Joyce Millen: Department of Social Medicine, Harvard University, Cambridge, MA
Mark Miller: Attorney, Greenbelt, MD
Maria A. Miralles: Senior Program Associate, Managment Sciences for Health, Arlington, VA
Claire Nader: Council for Responsible Genetics, Cambridge, MA
David C. Pang: Director of Scientific Affairs, American Association of Pharmaceutical Scientists, Alexandria, VA
Chris Pelloni: Senior Director, Pharm. R&D, TEVA Pharmaceuticals USA, Sellersville PA
Philip Peters: Alexis de Tocqueville Institution, Arlington, VA
Sara Radcliffe: R&D Policy Analyst, Alliance and Technology Group, SmithKline Beecham, Washington DC
Mukul Ranjan: National Heart Lung and Blood Institute, National Institute of Health, Bethesda, MD
John Richard: Center for Study of Responsive Law, Washington DC
Mary Rouleau: Consumer Federation of America, Washington DC
Larry D. Sasich: Research Analyst, Public Citizen Health Research Group, Washington DC
Kathy Scheetz: kathyscheetz@worldnet.att.net
Robert Weissman: Attorney, Essential Action, Washington DC
Sydney Wolfe: Health Research Group, Public Citizen, Washington DC
CANADA
Amir Attaran: Director, Malaria Project, Center for Study of Responsive Law, Washington DC
Jim Keon: Vice-President, Research & International Affairs, Canadian Drug Manufacturers Association, Toronto, Ontario
Joel Lexchin: Emergency Physician, The Toronto Hospital
EUROPE
Jerome Dumoulin: Institut de Recherche Economique sur la Production et le Developpement, Universite Pierre Mendes France, Grenoble, France
Beryl Leach: Project Officer for Policy and Campaigns, Health Action International (HAI - Europe)< Amsterdam, Netherlands
Greg Perry: Director, European Generic Medicines Association (EGA), Brussels, Belgium
German Velasquez: Health Economist, Action Programme on Essential Drugs (DAP), World Health Organization, Geneva, Switzerland
LATIN AMERICA
Jose Cabral De Barros: Health Action International, Recife, Brazil
German Rojas Caro: Accion International para la Salud (AIS), Lima, Peru
Carlos Correa: Professor, University of Buenos Aires, Argentina
Suzan Greenblatt: Accion International para la Salud (AIS), San Salvador
Carlos Ibanez Guzmann: Accion Internationa para la Salud (AIS), La Paz, Bolivia
Mirta Levis: Centro Industrial de Laboratorios Farmaceuticos Argentinos (CIFLA), Argentina
Roberto Lopez Linares: Coordinator Accion International para la Salud (AIS), Latin America
Benoit Marchand: Accion International para la Salud (AIS), Matagalpa, Nicaragua
Dolores Vicencio Acevedo: Accion International para la Salud, Mexico
AFRICA
Ian Roberts: Special Advisor to the Minister of Health, Ministry of Health, Government of South Africa, Cape Town, South Africa
ASIA
K. Balasubramaniam: Phamraceutical Adviser, Consumers International, Regional Office for Asia & the Pacific (ROAP), Penang, Malaysia
B.K. Keayla: Convenor, National Working Group on Patent Laws, India
Duangtip Hongsamoot: Inspector, Food and Drug Administration of Thailand, Ministry of Public Health, Thailand
Vithaya Kulsomboon: Doctoral Program in Pharmacey Administration, Chulalongkorn University, Thailand